Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03446105 · ClinicalTrials.gov registry record · NA

Promoting Quality of Life Among Young Adult Cancer Survivors

A NA study of Cancer, sponsored by Emory University.

Completed
Registry status
NA
Development phase
57
Enrollment target
2
Study locations

NCT03446105 is a NA study of Cancer that has completed, run by Emory University. The registered enrollment target is 57 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03446105, a NA study of Cancer, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
57 participants
Enrollment target
2
Study locations

Study Summary

This study expands on a prior pilot study to refine the intervention messaging to focus on goal-oriented thinking, include a coach, and extend the intervention to a larger sample of young adult cancer survivors (aged 18-39 years) recruited from two National Cancer Institute (NCI)-designated cancer centers (Emory's Winship Cancer Institute in Atlanta; University of Kentucky's Markey Cancer Center in Lexington). Participants will be randomly assigned (stratified by age and sex) to one of the 8-week treatment conditions in a 2:1 ratio (2 to intervention: 1 to attention control).

Conditions Studied

Interventions

  • BEHAVIORAL Attention control group
  • BEHAVIORAL App-based behavioral intervention

Study Locations (2)

Georgia

  • Emory University Winship Cancer Institute - Atlanta

Kentucky

  • Markey Cancer Center - Lexington

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2017-02-09
Est. Completion 2018-07-31
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT03446105

The ClinicalTrials.gov registry entry for NCT03446105 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Attention control group is the first listed.

NCT03446105 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Georgia, Kentucky.

Frequently Asked Questions

What is clinical trial NCT03446105 about?

NCT03446105 is a clinical study titled "Promoting Quality of Life Among Young Adult Cancer Survivors". This study expands on a prior pilot study to refine the intervention messaging to focus on goal-oriented thinking, include a coach, and extend the intervention to a larger sample of young adult cancer survivors (aged 18-39 years) recruited from two National Cancer Institute (NCI)-designated cancer c...

What is the current status of trial NCT03446105?

This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2017-02-09. Estimated completion is 2018-07-31.

What conditions does trial NCT03446105 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT03446105?

The interventions under investigation include: Attention control group (BEHAVIORAL), App-based behavioral intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03446105?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03446105 being conducted?

This trial has 2 study locations across Georgia, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.